Jaffe posits that the drop in A1c and LDL levels was not only due to a readjustment in dosage or a switch in medication, but also possibly to better complianceto existing medication in patients with the most elevated levels.
Other safeguards being proposed include guarantees about the storage and transportation of lethal medication, the reporting of assisted deaths and the powers for cases of non-compliance to be investigated.